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Abstract
Reverse transcriptases from HIV-1 and MuLV respectively prefer Mg2+  and Mn2+  for their
polymerase activity, with variable fidelity, on both RNA and DNA templates. The function of the
RNase H domain with respect to these parameters is not yet understood. To evaluate this function,
two chimeric enzymes were constructed by swapping the RNase H domains between HIV-1 RT
and MuLV RT. Chimeric HIV-1 RT, having the RNase H domain of MuLV RT, inherited the divalent
cation preference characteristic of MuLV RT on the DNA template with no significant change on
the RNA template. Chimeric MuLV RT, likewise partially inherited the metal ion preference of HIV-
1 RT. Unlike the wild-type MuLV RT, chimeric MuLV RT is able to use both Mn.dNTP and Mg.dNTP
on the RNA template with similar efficiency, while a 30-fold higher preference for Mn.dNTP was
seen on the DNA template. The metal preferences for the RNase H activity of chimeric HIV-1 RT
and chimeric MuLV RT were, respectively, Mn2+ and Mg2+, a property acquired through their
swapped RNase H domains. Chimeric HIV-1 RT displayed higher fidelity and discrimination against
rNTPs than against dNTPs substrates, a property inherited from MuLV RT. The overall fidelity of
the chimeric MuLV RT was decreased in comparison to the parental MuLV RT, suggesting that the
RNase H domain profoundly influences the function of the polymerase domain.
Introduction
Retroviral reverse transcriptases (RTs) are responsible for
copying the viral genomic RNA into double-stranded
DNA by a multi-step reverse transcription process. A con-
stituent of the pol gene, RT is proteolytically processed
from the gag-pol polyprotein precursor [1,2]. The subunit
organization of mature RTs from various viruses is differ-
ent. Reverse transcriptase from MMTV and MuLV [3,4] are
monomers, whereas those from HIV-1, HIV-2, SIV, FIV,
EIAV, and AMV are heterodimers. This enzyme is multi-
functional, exhibiting both RNA- and DNA-dependent
polymerase activities, as well as an RNase H activity that is
both polymerase-dependent and polymerase-independ-
ent [1,5-8]. Based on the amino acid sequence alignment
of the various reverse transcriptases and other polymer-
ases, it has been proposed that the DNA polymerase activ-
ity resides in the N-terminal domain, whereas the C-
terminal harbors the RNase H activity [9,10]. These
domain assignments are supported by mutational studies
[4] and confirmed by the availability of the 3-dimensional
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crystal structure of HIV-1 RT [11,12]. Considerable
homology exists between the RNase H domains of retro-
viral RTs and the E. coli RNase H [13-16]. In a model of the
MuLV RT RNase H domain based on the structure of E. coli
RNase H [13], the position of the active site residues,
D524, E562, D583, and D653, is similar to the position of
residues D443, E478, D498, and D549 in the crystal struc-
ture of HIV-1 RT RNase H [14], thus suggesting that they
share structural similarities.
There are two metal binding sites in the crystal structure of
HIV-1 RT RNase H, whereas only a single metal binding
site has been reported in E. coli RNase H [16]. However,
the co-crystal structure of E. coli RNase H with Mn2+ also
shows two distinct metal binding sites [17]. HIV-1 RT cat-
alyzes the double-stranded RNA cleavage in the presence
of Mn2+, while no such activity is seen with Mg2+, suggest-
ing distinct sites for these two metals [18]. This finding
has been supported by mutational studies. A point muta-
tion in the RNase H domain of HIV-1 RT substituting
Glu→Gln at the 478 position renders the enzyme inactive
with Mg2+, but retains Mn2+-dependent endoribonuclease
and double-stranded RNA cleavage (RNase H*) activities
[19].
As with HIV-1 RT, double- stranded RNA cleavage activity
of MuLV RT requires the presence of Mn2+ [20], although
both enzymes exhibit a distinct metal preference for their
polymerase and RNase H activities [21,22]. While MuLV
RT prefers Mn2+ as the divalent cation for both of these
activities, HIV-1 RT prefers Mg2+ for its polymerase reac-
tion. However, Mn2+ is also used, albeit with lower effi-
ciency [23,24]. In the RNase H domain of HIV-1 RT, Asp
443, Glu 478, and Asp 498 constitute the metal coordinat-
ing catalytic triad [14]. It has been suggested that the
fourth highly conserved residue, Asp 549, makes an
important contribution to RNase H activity, although it is
not absolutely required for metal coordination [24-26].
Structural and biochemical studies have demonstrated
that Asp 110, Asp 185, and Asp 186 constitute the metal
coordinating triad in the polymerase domain of HIV-1 RT
[11,12,27-29], while Asp 150, Asp 224, and Asp 225 form
the equivalent triad in MuLV RT [30,31].
The two domains of MuLV RT have been shown to be
independent of each other [4,32,33], in contrast to HIV-1
RT [25,34-37]. Earlier, we demonstrated that the polymer-
ase domain (p51) of HIV-1 RT lacking polymerase activity
can be converted to an active monomeric enzyme when
fused with the RNase H domain of MuLV RT [38]. This
observation confirms the functional dependence of the
polymerase domain of HIV-1 RT on the RNase H domain.
Neither the degree of functional interdependence of these
domains for their enzymatic activities nor the precise
nature of their effect on catalytic function is clear. To
explore the subtle influence of the RNase H domain on
the biochemical characteristics of the enzyme, we con-
structed two chimeric enzymes of HIV-1 RT and MuLV-RT
by swapping the RNase H domains between them. We
observed that the metal preference for the polymerase
activity of chimeric HIV-1 RT changed from Mg2+ to Mn2+,
a property inherited from MuLV RT via its RNase H
domain. Here we provide evidence that the metal prefer-
ence, as well as substrate specificity for the polymerase
function of the chimeric RTs, is influenced by the RNase
H domains.
Materials and methods
Materials
DNA restriction enzymes, DNA modifying enzymes, and
dNTP solutions were purchased from Roche Molecular
Biochemicals. Fast-flow chelating Sepharose (iminodiace-
tic Sepharose) for immobilized metal affinity chromatog-
raphy (IMAC) was purchased from Amersham Pharmacia
Biotech, 32P-labeled dNTPs and ATP were the products of
NEN. The RNA and DNA oligomers used as template
primers were synthesized at the Molecular Resource Facil-
ity at UMDNJ and have the same sequence as described
before [38]. Other reagents, all were of the highest availa-
ble purity grade, were purchased from Fisher, Millipore
Corp., Roche Molecular Biochemicals, and Bio-Rad.
Construction and Expression of Chimeric Enzymes
Our group has previously described the construction of
chimeric HIV-1 RT containing the polymerase domain of
HIV-1 RT and the RNase H domain from MuLV RT [38].
The chimeric MuLV RT, having the polymerase domain of
MuLV RT and the RNase H domain from HIV-1 RT, was
constructed using pET28a-MRT [39] and pKK-RT66 [40-
42]; these were the respective sources of the complete cod-
ing sequence of MuLV RT and HIV RT. The polymerase
domain of MuLV RT, starting from 1 bp-1,560 bp was
PCR-amplified using the upstream primer (5' TAT GGG
GCC ATA TGA ATA TAG AAG ATG AG 3') and the down-
stream primer (5' TGG CGA GCT CTA CGT ACC AGG
TGG GGT CGG CGT 3'), and pET28aMRT as a template.
The upstream and downstream primers respectively con-
tained the unique restriction sites Nde1 and Sac1. The PCR
amplified fragment was digested with NdeI and SacI, and
cloned at the compatible ends in pET28a. The resulting
plasmid (pET28aMPol) was expressed in E. coli as the
polymerase domain for MuLV RT (M-Pol). Similarly, the
RNase H domain of HIV-1 RT starting from 1,324 bp-
1,680 bp was PCR-amplified using the upstream primer
(5'-CCC AGA CGC CGA CAC CTG GTA GGT AGA TGG
GGC AGC TAA CAG G-3'), and the downstream primer
(5'-TAT AGG GAC CCT CGA GTA GTA CTT TCC TGA TTC
CAG C3'), and pKKRT66 as the template. This PCR-ampli-
fied fragment was subcloned at the SnaBI and XhoI sites of
pET28a-M-POL. The recombinant plasmid thus obtained,Virology Journal 2009, 6:159 http://www.virologyj.com/content/6/1/159
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pET28a-MHCI, was expressed in E. coli BL21 (DE3) pLysS
as MHCI RT.
Glycerol gradient ultracentrifugation
Fifty micrograms of each enzyme protein in Tris - NaCl
buffer (50 mM Tris HCl, pH 8.0, and 400 mM NaCl) was
loaded onto 5 ml of 10%-30% linear glycerol gradient
prepared in the same buffer [38]. Gradients were centri-
fuged at 48,000 rpm for 20-24 h in a SW 50.1 rotor. Gra-
dients were fractionated from the bottom and subjected to
SDS-polyacrylamide gel electrophoresis to determine the
protein peak fraction.
Polymerase Assay
The activity of the wild-type and chimeric enzymes was
determined using the homopolymeric template primer
poly (rA). (dT)18 and the heteropolymeric U5-PBS HIV-1
RNA, with DNA templates primed with 17-mer PBS
primer as described before [42]. In brief, 50 μl of the reac-
tion mixture contained 50 mM Tris-HCl (pH 7.8); 100 μg/
ml bovine serum albumin; 2 mM MgCl2  or 0.5 mM
MnCl2; 1 mM dithiothreitol; 60 mM KCl; 100 nM tem-
plate primer;100-500 μM of all four dNTPs (or TTP alone
with homopolymeric rA.dT); 0.5 μCi of α-32P-labeled TTP
or 0.5 μCi each of α-32P-labeled TTP; dGTP per reaction
for heteropolymeric templates; and 15-25 nM of the
enzyme. Reactions were done at 37°C for the desired time
and terminated by the addition of ice cold 5% trichloro-
acetic acid containing 5 mM inorganic pyrophosphate.
The acid-insoluble materials were filtered on Whatman
GF/B filters, dried, and counted for radioactivity in a liq-
uid scintillation counter.
RNase H Activity Assay
We used a 5'-32P labeled 30-mer synthetic U5-PBS RNA
template annealed with a complementary 30-mer DNA to
determine the RNase H activities of the enzymes [38]. The
reaction mixture contained labeled RNA-DNA hybrid (20
K cpm); 60 mM KCl; 5 mM MgCl2 or 0.5 mM MnCl2; 10
mM dithiothreitol; 50 mM Tris-HCl, pH 8.0; 0.1 mg/ml
bovine serum albumin; and 100 ng of enzyme in a final
volume of 5 μL. Reactions were done at 37°C for variable
times and terminated by the addition of equal volumes of
Sanger's gel loading dye [43]. The cleavage products were
analyzed on an 8% denaturing polyacrylamide-urea gel
and scanned on a phosphorImager (Molecular Dynam-
ics).
Steady-State Kinetic Assays
Kinetic parameters in the presence of Mg2+ or Mn2+ were
determined using heteropolymeric RNA and DNA tem-
plates as described [42,44,45], except that reactions were
done at 37°C instead of room temperature. The concen-
tration of metal ions used was 2 mM Mg2+; 0.5 mM Mn2+.
Km and kcat values were determined from the Eadie- Hoft-
see plots using the enzyme kinetic program.
Gel Shift Assay
The Kd values for template-primer (DNA-DNA) binding to
the wild- type enzymes and their chimeric derivatives were
determined by gel mobility shift assay using 32 P-labeled
17-mer PBS primer annealed with the 49-mer DNA tem-
plate. The labeled template-primer was present at a final
concentration of 5 nM in a total reaction volume of 10 μL
containing 50 mM Tris-HCl (pH 7.8), 60 mM KCl, 1 mM
DTT, 0.01% NP40, 10% glycerol, and varying concentra-
tions of enzyme proteins. Samples were loaded on a 6%
nondenaturing polyacrylamide gel in Tris-borate buffer,
pH 8.2. The gel was run at 150 V at 4°C, dried, and sub-
jected to phosphorimaging. The enzyme-DNA binary
complex was quantitated using Image Quant software
(Molecular Dynamics). The fraction of bound DNA was
plotted against the enzyme concentration and the Kd
value was obtained as the RT concentration at which 50%
of the DNA was bound.
Gel Analysis of Primer Extension Products in the Presence 
ofrNTP Substrates
The ability of the wild-type enzymes and their chimeric
derivatives to extend the primer by incorporating ribonu-
cleotides was assessed on both U5-PBS RNA and U5-PBS
DNA templates primed with 5'-32P-labeled PBS DNA
primer as described [44-46]. Reactions were initiated by
the addition of 500 μM of Mg.rNTP in a final reaction vol-
ume of 5 μL. For comparison, control reactions were also
done in the presence of dNTP substrates. The reaction
mixtures were incubated at 37°C for 10-30 min and ter-
minated by the addition of an equal volume of Sanger's
gel loading dye. The reaction products were resolved by
denaturing 12% polyacrylamide-8M urea gel electro-
phoresis and subjected to phosphorimaging.
Extension of Primers in the Presence of Three dNTPs
5'-32P-labeled 17-mer primer annealed with a 2-fold
molar excess of 49-mer U5-PBS HIV-1 DNA template was
used to assess the fidelity of nucleotide incorporation
under conditions in which the biased dNTP pools con-
taining only three dNTPs were supplied [47]. The labeled
template primer was incubated with the enzymes at 37°C
for 30 min in a total volume of 5 μl containing 50 mM
Tris-HCl (pH 7.5), 1 mM DTT, 0.1 mg/ml BSA, 2 mM
MgCl2 and only 3 dNTPs, each at a 100-μM concentration.
The dNTPs used were of the highest available purity grade
(HPLC purified) and supplied as 0.1 M solution (Boe-
hringer Mannheim). At the end of incubation, the reac-
tion was quenched by the addition of 5 μl of stop solution
containing 40 mM EDTA, 0.014% each of bromophenol
blue and xylene cyanol, and 85% formamide. The reac-
tion products were analyzed on a denaturing 8% polyacr-Virology Journal 2009, 6:159 http://www.virologyj.com/content/6/1/159
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ylamide-8 M urea gel and visualized on a
phosphorimager.
Results
Construction, Expression, and Purification of the 
ChimericEnzymes
The chimeric HIV-1 RT and MuLV RT were constructed by
swapping the RNase H domain between the reverse tran-
scriptases from HIV-1 and MuLV (Figure 1A). The wild-
type enzymes and their chimeric derivatives were
expressed in E. coli and purified to homogeneity. The chi-
meric enzymes were in the soluble fraction of the cell
extract. Their expression and gel electrophoresis patterns
were similar to those of the wild-type enzyme, indicating
that there was no deleterious change in their global con-
formation. The purity of the enzyme preparations was
greater than 95%. An SDS-polyacrylamide gel of purified
enzymes stained with Coomassie blue is shown in Figure
1B. The enzyme stocks were stored at -70°C for several
months without any significant change in polymerase
activity.
Dimeric/Monomeric Conformation of the Chimeric 
Enzymes
Earlier, we showed that the chimeric HIV-1 RT containing
the native DNA polymerase domain from HIV-1 RT and
the exotic RNase H domain from MuLV RT is functionally
active in the monomeric conformation [38]. To determine
the subunit organization of the chimeric MuLV RT con-
taining the exotic RNase H domain from HIV-1 RT, we
therefore performed sedimentation analysis of the chi-
meric MuLV RT, along with the chimeric HIV-1 RT, and
their wild-type parental enzymes [38]. The fractions were
collected from the bottom and an aliquot of each fraction
was analyzed by SDS polyacrylamide gel electrophoresis
followed by Coomassie blue staining. Both the chimeric
RTs, as well as monomeric MuLV RT, sedimented as mon-
omeric proteins between fractions 25-29, whereas the
dimeric HIV-1 RT sedimented at the bottom of the gradi-
ent, between fractions 17-21 (Figure 2). This sedimenta-
tion profile of the chimeric RTs clearly suggests their
monomeric status.
(A) Schematic representation showing the polymerase connection and RNase H domains of wild-type RTs and their chimeric  derivatives Figure 1
(A) Schematic representation showing the polymerase connection and RNase H domains of wild-type RTs and 
their chimeric derivatives. Swapping of the RNase H domain between the wild-type HIV-1 RT and MuLV RT to construct 
their chimeric derivatives is shown by arrows. (B) Coomassie Blue stained SDS polyacrylamide gel of the wild-type 
enzymes and their chimeric derivatives. An aliquot of purified chimeric enzymes, M-pol, wild-type p66/66 HIV-1 RT, and 
MuLV RT was resolved by SDS-PAGE; protein bands were visualized by Coomassie blue staining. In the wild-type HIV-1 RT 
lane, the minor band seen at the 51 kD position may have been generated by proteolytic cleavage during purification. The posi-
tions corresponding to 66 kD and 51 kD are indicated on the leftVirology Journal 2009, 6:159 http://www.virologyj.com/content/6/1/159
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Metal Preference for the Polymerase Activity Catalyzed by 
the Wild-Type Enzymes and Their Chimeric Derivatives
The RNA-dependent DNA polymerase activity of the chi-
meric enzymes was examined using the homopolymeric
poly (rA). (dT)18 and the heteropolymeric U5-PBS RNA
transcript primed with the 17-mer PBS DNA primer. The
percentage activity of these enzymes with respect to the
wild-type enzyme at 500 μM substrate concentration is
shown in Table 1. Wild-type HIV-1 RT consistently
showed higher DNA polymerase activity on all three tem-
plates with Mg2+ as the divalent cation, while the reverse
was true with the wild-type MuLV RT. In contrast, chi-
meric HIV-1 RT containing the RNase H domain from
MuLV RT exhibited a preference for Mn2+ with heteropol-
ymeric U5-PBS DNA and homopolymeric RNA templates,
but for Mg2+ with a heteropolymeric RNA template. This
change in metal preference may be a consequence of the
presence of the RNase H domain of MuLV RT. A similar
change in metal preference was also observed with chi-
meric MuLV RT containing the RNase H domain from
HIV-1 RT. This enzyme exhibited similar preference for
Mg2+ and Mn2+ with DNA template, while retaining a
strong preference for Mn2+ with RNA templates. Curi-
ously, M-Pol of MuLV RT (devoid of the RNase H
domain) is able to use Mg2+ and Mn2+ to the same extent
with heteropolymeric RNA (65%-68%) and DNA tem-
Glycerol gradient ultracentrifugation analyses of the wild-type enzymes and their chimeric derivatives Figure 2
Glycerol gradient ultracentrifugation analyses of the wild-type enzymes and their chimeric derivatives. The 
enzyme proteins were individually resolved by glycerol gradient ultracentrifugation analysis as described. Gradients were frac-
tionated from the bottom and subjected to SDS polyacrylamide gel electrophoresis followed by Coomassie blue staining.
Table 1: Polymerase Activity of the Wild-Type and Chimeric Reverse Transcriptase
Percentage of Wild-Type HIV-1 RT Polymerase Activity
Enzyme Poly
(rA).(dT)18
U5-PBS RNA/17mer DNA U5-PBS 49mer DNA/17mer DNA
Mg2+ Mn2+ Mg2+ Mn2+ Mg2+ Mn2+
WT HIV-1 RT 100
(22649)
100
(6182)
100
(4500)
100
(3740)
100
(2721)
100
(2451)
Chimeric HIV-1 RT 24 96 91 69 46 58
WT MuLV RT 130 331 71 95 58 68
Chimeric MuLV RT 80 477 108 183 81 72
MuLV RT- Pol Domain 88 221 65 68 48 52
The polymerase activities of wild-type reverse transcriptase enzymes and their chimeric derivatives were determined on homopolymeric and 
heteropolymeric template primers in the presence of Mg2+ or Mn2+ as the divalent cation. The values represent the percentage of WT HIV-1 RT 
activity. Data shown are the average of three independent experiments. The values in parentheses are the total cpm of acid-insoluble dNMP 
incorporated into the primer DNA by 100 ng of the WT HIV-1 RT at 37°C in 15 min. These determinations were done at saturating substrate 
concentrations (500 μM of each dNTP).Virology Journal 2009, 6:159 http://www.virologyj.com/content/6/1/159
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plates (48%-52%) while retaining wild- type preference
for Mn2+ on the homopolymeric RNA template. The activ-
ity profile (Table 1) determined with saturating concen-
trations of the metal complexed dNTPs (2 mM) may not
reflect true metal preference. Therefore, to assess the metal
ion preference of the chimeric enzymes, we determined
their steady-state kinetic parameters in the presence of dif-
ferent metal ions.
Influence of Mg2+ and Mn2+ on Steady-State Kinetic 
Parameters of the Wild-Type Enzymes and Their Chimeric 
Derivatives
The change in metal ion preference observed with the chi-
meric derivatives of HIV-1 RT and MuLV RT suggests that
swapping the RNase H domains between these two RTs
imparts some of the characteristics of the parental
enzyme. Exploring this possibility, we examined the
kinetic parameters of the wild-type enzymes and their chi-
meric derivatives on U5-PBS RNA and DNA templates. As
shown in Table 2, the metal ion preference of chimeric
HIV-1 RT exhibited earlier (see Table 1) was confirmed by
our steady-state kinetic studies. The catalytic efficiency
(kcat/Km) for this chimeric enzyme was approximately
two-fold higher with Mn2+ than with Mg2+ on the DNA
template and two-fold higher with Mg2+ on the RNA tem-
plate. Chimeric MuLV RT, on the other hand, exhibited
equal catalytic efficiency with both metal ions on the RNA
template while retaining the parental preference for Mn2+
on the DNA template. In contrast, M-Pol of MuLV RT
retained its parental characteristics, having consistently
higher catalytic efficiency with Mn2+ on both RNA and
DNA templates. These results are in contrast to those
shown in Table 1. A possible explanation for this discrep-
ancy is that the activity assays in Table 1 were done in the
presence of saturating concentrations of metal complexed
dNTP (2 mM). Under these experimental conditions, the
subtle differences in the metal preference noted in the
kinetic analysis were abolished.
This observation suggests that the ability of the chimeric
MuLV RT to use Mg.dNTP as efficiently as it does
Mn.dNTP on an RNA template may be due to the presence
of the RNase H domain of HIV-1 RT. As expected, the
wild-type HIV-1 RT and MuLV RT enzymes respectively
preferred Mg2+ and Mn2+ as the divalent cation on both
RNA and DNA templates, as shown by their catalytic effi-
ciency values. Although, as compared to that of their wild-
type parental enzymes, the catalytic efficiencies of the chi-
meric enzymes were reduced by 2-384-fold (depending
on the template used), the subtle changes in their metal
preferences appeared to be dictated by the specific RNase
H domain in the chimeric enzyme.
Template Primer Binding Affinity of the Chimeric Enzyme
The lower affinity for dNTPs observed in the chimeric
enzymes in the presence of both the metal ions could be
due to their altered affinity for the template primer. We
therefore determined their template primer binding affin-
ity by gel shift analysis and compared it with those of the
parental wild-type enzymes. The results showed no signif-
icant difference in the binding affinity of these chimeric
enzymes as compared to that of their wild-type counter-
parts (Table 3). These results suggest that the altered
kinetic parameters observed for the dNTP substrates are
not related to any change in template-primer binding
affinity.
Use of rNTP versus dNTP Substrates
Since there was a significant change in metal preference
for the polymerase function of the chimeric enzymes, it
was of interest to examine whether the swapping of the
RNase H domains effected any change with respect to sub-
Table 2: Steady State Kinetic Parameters of the Wild Type and Chimeric Reverse Transcriptases
Template-primer Enzyme KmdNTP μMM n 2+ Kcat S-1 Kcat/Km
S-1 M-1 × 102
KmdNTP μMM g 2+ Kcat S-1 Kcat/Km
S-1 M-1 × 102
U5-PBS RNA/17-mer DNA WT HIV-1 RT 5.8 0.009 15.5 1.7 0.005 29.4
Chim HIV-1 RT 945.5 0.040 0.4 702.8 0.050 0.7
WT MuLV RT 2.0 0.003 15.0 16.7 0.006 3.6
Chim MuLV RT 197.6 0.040 2.0 157.0 0.030 1.9
M-Pol 2.9 0.004 13.8 301.8 0.021 0.7
U5-PBS 49-mer DNA/17-mer 
DNA
WT HIV-1 RT 2.8 0.029 103.6 1.3 0.035 269.2
Chim HIV-1 RT 204.8 0.024 1.2 691.0 0.048 0.69
WT MuLV RT 1.6 0.013 81.3 10.6 0.015 14.2
Chim MuLV RT 14.8 0.055 37.2 433.0 0.048 1.1
M-Pol 1.4 0.012 85.7 181.5 0.017 0.94
The steady-state kinetic parameters for wild-type reverse transcriptase from HIV-1 and MuLV and their chimeric derivatives were measured on 
heteropolymeric RNA and DNA template-primer in the presence of Mg+2 and Mn+2 as the divalent cation. These determinations were carried out 
at subsaturating concentration of dNTP substrates.Virology Journal 2009, 6:159 http://www.virologyj.com/content/6/1/159
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strate discrimination. We therefore examined the ability
of the wild-type enzymes and their chimeric derivatives to
catalyze the incorporation of rNTPs, using the DNA and
RNA templates (Figure 3). The extent of rNTP incorpora-
tion with a DNA template by the wild-type HIV-1 RT was
greater than that of all other enzymes (Figure 3A). As
judged by the band intensity, wild-type HIV-1 RT effi-
ciently incorporated a stretch of several ribonucleotides.
In contrast, poor incorporation by the chimeric HIV-1 RT
and wild-type MuLV RT was observed. This characteristic
of the chimeric HIV-1 RT may be attributed to the pres-
ence of the RNase H domain of MuLV RT. In contrast, the
rNTP incorporation pattern of M-Pol and chimeric MuLV
RT is closely similar to that of the wild-type MuLV RT.
Interestingly, all the enzymes except wild-type HIV-1 RT
were found to catalyze the cleavage of 3' primer nucle-
otide in the presence of rNTPs, especially on a DNA tem-
plate. This may be caused either by pyrophosphorolysis
resulting from PPi contamination of the commercial
nucleotide preparations or by rNTP-dependent transfer of
3' nucleotide from the primer terminus to rNTP [48].
Cleavage products are abundant in enzymes that are less
efficient in rNTP incorporation. With RNA template, wild-
type HIV-1 RT is able to incorporate ribonucleotides to a
greater extent as compared to that seen with the DNA tem-
plate (Figure 3B). A similar pattern of rNTP incorporation
occurred with the chimeric HIV-1 RT, wild-type MuLV RT,
and its pol domain; chimeric MuLV RT exhibited a
reduced level of rNTP incorporation
Fidelity of DNA Synthesis
Since, much like the wild-type MuLV RT, the chimeric
HIV-1 RT with the RNase H domain of MuLV RT could
discriminate between rNTPs and dNTPs, we examined
whether swapping of the RNase H domain influenced the
stringency of substrate dNTP selection. We analyzed the
pattern of synthesis and extension of the various mispairs
by the chimeric enzymes and compared them with those
of the wild-type HIV-1 RT and MuLV RT. To determine the
pattern of misincorporation at the template position com-
plementary to the missing dNTP, we used the U5-PBS
DNA template primed with 5'-32P 17-mer PBS primer. For
each enzyme, we did four separate reactions in which one
of the dNTPs was excluded.
In Figure 4, lanes 1-4 represent the reaction conditions in
which dATP, dCTP, dGTP, and dTTP were omitted to
assess the extent of mispair formation against T, G, C, and
A template nucleotides. In all reactions, irrespective of the
enzyme, a substantial accumulation of the DNA product
occurred at a site before the position of the corresponding
missing nucleotide from the reaction mixture. Extension
Table 3: Kd Values for Wild-Type Reverse Transcriptases and 
Their Chimeric Derivatives
Enzymes Kd (DNA)
(nM)
Wild-type HIV-1 RT 3.20
Chimeric HIV-1 RT 1.50
Wild-type MuLV RT 2.70
Chimeric MuLV RT 3.3
M-pol 1.2
The dissociation constant was determined by a mobility shift assay 
using a hetero-polymeric 49/17-mer template primer. The values 
represent the average of three independent experiments.
Use of rNTPs by wild-type RTs and their chimeric derivatives Figure 3
Use of rNTPs by wild-type RTs and their chimeric 
derivatives. The ability of reverse transcriptases from the 
wild type HIV-1 and MuLV and their chimeric derivatives to 
incorporate rNTPs was examined on 49-mer U5-PBS DNA 
(Panel A) and U5-PBS-RNA (Panel B) templates primed 
with the 5'-32P-labeled 17-mer PBS DNA primer. Reactions 
were done at 37°C for 30 min as described in Materials and 
Methods. Lanes 1 and 2 in each panel represent extension 
reactions done in the presence of 500 μM of dNTPs and 
rNTPs, respectively.Virology Journal 2009, 6:159 http://www.virologyj.com/content/6/1/159
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of the misincorporated products into longer products was
also evident. However, the extent of mispair extensions
differed in case of both RTs and their chimeric derivatives.
As shown in Figure 4, HIV-1 RT catalyzes the mispair syn-
thesis and its extension against all the template bases on
the DNA template. In contrast, the extent of mispair syn-
thesis and its extension against dT base (see -A lane) cata-
lyzed by the chimeric HIV-1 RT is drastically reduced and
similar to MuLV RT, suggesting a possible influence of the
RNase H domain of the latter on the polymerase domain
of HIV-1 RT. Wild-type MuLV RT characteristically exhib-
ited a significantly higher fidelity than did the wild-type
HIV-1 RT. Interestingly, the chimeric HIV-1 RT exhibited
higher overall fidelity than did the parental wild-type
enzyme, whereas the chimeric MuLV RT had lower fidelity
than did the parental wild-type MuLV RT. These results
imply that the RNase H domain also contributes to sub-
strate selection and its discrimination. The substrate selec-
tion pattern of the M-Pol of MuLV RT was similar to that
of the wild-type enzyme, suggesting that the polymerase
domain of MuLV RT is a dominant factor in substrate
selection.
Metal Preference for RNase H Activity
Since the metal ion preference for the polymerase activity
of the chimeric HIV-1 RT and chimeric MuLV RT is signif-
icantly altered due to swapping of the RNase H domains,
we examined whether these chimeric enzymes display
similar metal preference for RNase H activity. Using a 30-
mer RNA-DNA hybrid, we evaluated the cleavage pattern
of the 5'-32P-RNA strand of the duplex by wild-type
enzymes and their chimeric derivatives. As shown in
panel A of Figure 5, the initial cleavage of the 30-mer RNA
strand by the wild-type HIV-1 RT at 30 sec (lane 1) and 2
min (lane 2) was similar in the presence of either Mg2+ or
Mn2+, though the processive degradation was highest with
Mg2+during further incubation (panel B) for 15 min (lane
1) and 30 min (lane 2). In contrast, chimeric HIV-1 RT
exhibited an interesting pattern in response to Mg2+ and
Mn2+. In the presence of Mg2+, initial cleavage of the RNA
strand was significantly low (panel A). Processive degra-
dation was observed in the presence of Mg2+ only after
incubation for 15 min and 30 min (panel B), while in the
presence of Mn2+ both initial cleavage and progressive
degradation could be seen within 30 sec and 2 min, sug-
gesting that this enzyme prefers Mn2+ for its RNase H
activity. As expected, MuLV RT displayed a greater prefer-
ence for Mn2+ for its RNase H activity. Interestingly, chi-
meric MuLV RT cleaved the RNA strand only in the
presence of Mg2+; no cleavage activity could be detected
with Mn2+ even after prolonged incubation (panel B).
These results clearly suggest that the metal ion preference
for RNase H activity is dictated by the parental RNase H
domain.
Discussion
In the present study we have investigated the role of the
RNase H domain of retroviral reverse transcriptase with
respect to the substrate selection and metal specificity of
their polymerase domains, using HIV-1 RT and MuLV RT
as the model enzymes. These enzymes exhibit different
polymerase and RNase H activities in response to Mg2+
and Mn2+. MuLV RT exhibits approximately 16-fold
higher RNase H activity [20] and 10-fold higher polymer-
ase activity on a homopolymeric poly rA template [21]
when Mn2+ is used instead of Mg2+ as the divalent cation.
In contrast, the polymerase activity of HIV-1 RT is 20- to
50-fold higher in the presence of Mg2+[23], while its
RNase H activity displays no distinct preference for these
metal ions [19]. Interestingly, the fidelity characteristics of
DNA synthesis catalyzed by these two enzymes signifi-
cantly differ, with HIV-1 RT being more prone to make
error in DNA synthesis than is MuLV RT. In HIV-1 RT, the
catalytic centers of these two domains are separated by
approximately 20-21 nucleotides [26]. Specific mutations
in the polymerase domain result in the loss of RNase H
function, suggesting that these domains, although spa-
tially distinct, are able to communicate with each other.
Fidelity of DNA synthesis by wild-type enzymes and their  chimeric derivatives on 49-mer U5-PBS DNA template in the  presence of three dNTPs Figure 4
Fidelity of DNA synthesis by wild-type enzymes and 
their chimeric derivatives on 49-mer U5-PBS DNA 
template in the presence of three dNTPs. The ability of 
the enzymes to generate and extend mispair in the presence 
of three dNTPs was assessed on a 49-mer U5-PBS DNA 
template. The reaction products were analyzed on a denatur-
ing 8% polyacrylamide-urea gel followed by phosphorImager 
analysis. Lanes 1-4 represent the products formed in the 
absence of dATP, dCTP, dGTP, and dTTP, respectively. Lane 
5 represents the products synthesized in the presence of all 
four dNTPs. The position of the 17-mer PBS primer is indi-
cated on the left.Virology Journal 2009, 6:159 http://www.virologyj.com/content/6/1/159
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For instance, mutation in the primer grip region in the
polymerase domain of HIV-1 RT causes loss of RNase H
activity [49,50]. Similarly, a point mutation at position 55
or 156 in the polymerase domain abolishes RNase H
activity without significantly affecting polymerase activity
[51]. Similarly, expression of the C-terminal RNase H
domain of HIV-1 RT resulted in a soluble protein of 15 kD
with no detectable enzymatic activity [37,52-54].
Interestingly, the RNase H activity of the 15 kD protein
could be restored when that protein was mixed with the
polymerase domain of HIV-1 RT (p51 subunit), suggest-
ing a close functional relationship between the two
domains [37]. In contrast to HIV-1 RT, the polymerase
and RNase H domains of MuLV RT are relatively inde-
pendent of each other [4,53,55,56]. However, a deletion
in the connection subdomain or replacement of the
RNase H domain of MuLV RT with the E. coli RNase H
domain resulted in altered levels of polymerase and
RNase H activities, indicating that an interaction between
the two domains may exist under physiological condi-
tions [57,58].
To assess how these two domains affect each others' bio-
chemical characteristics, we constructed two chimeric RTs,
as described. In-depth biochemical examination of the
chimeric HIV-1 RT and MuLV RT has provided evidence
that their extrinsic RNase H domain exhibits significant
influence on the substrate and metal ion specificity of
their native polymerase domain. The chimeric enzymes
we constructed, in contrast to an earlier report [53], exhib-
ited both DNA polymerase and RNase H activities. Under
our assay conditions, chimeric HIV-1 RT displayed a dis-
tinct preference for Mn2+ for polymerase activity on a DNA
template (Tables 1 and 2), while its catalytic efficiency on
an RNA template with Mn2+ was similar to that of Mg2+. In
contrast, chimeric MuLV RT retained its distinct prefer-
ence for Mn2+ on a DNA template, while displaying simi-
lar catalytic efficiency with Mn2+ and Mg2+ on an RNA
template, suggesting that its pol domain is the dominant
factor in metal preference. However, the metal preference
of chimeric MuLV RT on an RNA template was signifi-
cantly altered. As against its parental wild type enzyme,
the chimeric MuLV RT manifested similar catalytic effi-
ciency with Mn2+ and Mg2+ on RNA template.
Post et al., [57] showed that a chimeric RT construct con-
taining the pol domain from MuLV RT and the RNase H
domain from E. coli functions in a fashion similar to E. coli
RNase H, exhibiting nearly 300-fold higher activity with
Mg2+ as the divalent cation [57]. However, these authors
did not report the influence of E. coli RNase H on the
metal preference of the chimeric enzyme for polymerase
activity. Post et al., [57] also demonstrated that after dele-
tion from MuLV RT of the specific region corresponding to
the connection subdomain of HIV-1 RT, MuLV RT dis-
played negligible polymerase activity but retained RNase
H activity with Mn2+, suggesting the importance of the
RNase H activity of wild-type enzymes and their chimeric derivatives Figure 5
RNase H activity of wild-type enzymes and their chimeric derivatives. 5'-32P-labeled 30-mer RNA annealed with its 
complementary 30-mer DNA strand was incubated at 37°C with the wild-type RTs and their chimeric derivatives under stand-
ard reaction conditions. The reactions were analyzed on an 8% denaturing polyacrylamide-urea gel. Panels A and B indicate 
reactions carried out at lower and higher time points, respectively.Virology Journal 2009, 6:159 http://www.virologyj.com/content/6/1/159
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proper spatial relationship between the two catalytic cent-
ers [57].
Although, the chimeric RTs we constructed contained an
intact DNA polymerase domain from their wild-type par-
ents, both of them displayed a large increase in their
Km[dNTP] in the presence of both Mn2+ and Mg2+. These chi-
meric enzymes displayed DNA binding affinities (Kd[DNA])
similar to those of the wild-type enzyme (Table 3), indi-
cating that the change in the metal preference or the affin-
ity for the substrate is not due to alteration in their DNA
binding ability. Thus, the apparent increase in Km[dNTP]
may be due to changes in the substrate-binding pockets of
these enzymes. Further, the relatively lower fidelity of the
chimeric MuLV RT and the greater stringency in discrimi-
nation of rNTPs versus dNTPs observed with the chimeric
HIV-1 RT, especially with a DNA template, indicate that
the RNase H domain has a significant effect on the geom-
etry of their substrate binding pockets. It is possible that
in the chimeric RTs, the metal coordinating pocket may
have acquired distinct conformation with RNA-DNA and
DNA-DNA template primer. Alternatively, the metal bind-
ing pocket in the chimeric enzymes may have altered as a
consequence of global change in their conformation.
Taken together, the present studies clearly demonstrate
that spatially distinct polymerase and RNase H domains
in retroviral RTs communicate and exert significant influ-
ence on each other's functions.
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